Search
for
Sort by
Research 541–570 of 1000+
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Selective and rapid determination of tadalafil and finasteride using solid phase extraction by high performance liquid chromatography and tandem mass spectrometry
- Measurement of tamsulosin in human serum by liquid chromatography–tandem mass spectrometry
- Phenomenology of polymorphism: The topological pressure–temperature phase relationships of the dimorphism of finasteride
- 술 전 5-알파환원효소억제제의 투여가 120W Greenlight TM HPS 레이저를 이용한 광선택적 전립선기화술에 미치는 영향
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids
- The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption
- Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
- Common urologic diseases in older men and their treatment: how they impact fertility
- Effects of <i>In Utero</i> Exposure to D-004, a Lipid Extract from <i>Roystonea regia</i> Fruits, in the Male Rat: A Comparison with Finasteride
- 1194: The Long Term Effects of Doxazosin, Finasteride, and the Combination on Sexual Function in Men Participating in the MTOPS Study
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Risk of Depression Associated With Finasteride Treatment
- Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden
- Post-finasteride syndrome – does it really exist?
- Assessing dutasteride-associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System
- Association between male pattern baldness and prostate disease: A meta-analysis
- Finasteride and the Uncertainties of Establishing Harms
- An update on the use of 5alpha-reductase inhibitors
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- The postfinasteride syndrome; an overview
- An observational study of the association between androgenetic alopecia and size of the prostate
- Steroid 5α-reductase inhibition by polymethoxyflavones
- Bioequivalence Study of Finasteride
- Aphalangia possibly linked to unintended use of finasteride during early pregnancy
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- Homology Modeling of 5-alpha-Reductase 2 Using Available Experimental Data
- Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure
- Discovery of novel 5α-reductase type II inhibitors by pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulations